Evidence map›Paper›PMID 23975881›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2014

Advancing the understanding of craving during smoking cessation attempts: a demonstration of the time-varying effect model.

Stephanie T Lanza, Sara A Vasilenko, Xiaoyu Liu, Runze Li, Megan E Piper

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 83 citations in OpenAlex.

  1. Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  2. Time-Varying Mediation of Pharmacological Smoking Cessation Treatments on Smoking Lapse via Craving, Cessation Fatigue, and Negative Mood.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  3. Day-level shifts in social contexts during youth cannabis use treatment.Journal of consulting and clinical psychology · 2021
    Trial
  4. Trial
  5. Trial
  6. Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Trial
  7. Trial
  8. The Dynamic Role of Urban Neighborhood Effects in a Text-Messaging Adolescent Smoking Intervention.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Trial
  9. Trial
  10. Exploring the nature and relationship of tobacco cigarette craving and withdrawal.Journal of psychopathology and clinical science · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mobile Health Interventions for Substance Use Disorders.Annual review of clinical psychology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie T LanzaMethodology Center, Pennsylvania State University, University Park, PA;
Sara A Vasilenko
Xiaoyu Liu
Runze Li
Megan E Piper
Pennsylvania State University · USUniversity of Wisconsin–Madison · US

Funding

THE REFINEMENT &APPLICATION OF MEDICAL DECISION MAKING IN PREVENTION SCIENCESP50DA010075 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI MURPHY, SUSAN A · 1996 to 2014
$24.5M
ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AMLM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI GOLDEN, ROBERT NEAL · 1986 to 2007
$19.3M
Enhancing the Effectiveness of Varenicline Based Smoking Cessation TreatmentR01HL109031 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, STEIN, JAMES H · 2011 to 2020
$17.5M
PREVENTION AND METHODOLOGY TRAINING (PAMT)T32DA017629 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI Eric D Claus, Rina D Eiden · 2005 to 2026
$9.5M
RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
New Statistical Models for Intensive Longitudinal DataR21DA024260 · NIDA · PENNSYLVANIA STATE UNIVERSITY, THE · PI DIERKER, LISA C, LI, RUNZE · 2007 to 2010
$1.2M
Advancing Tobacco Research by Integrating Systems Science and Mixture ModelsR01CA168676 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI LANZA, STEPHANIE T · 2012 to 2014
$498k
NCI NIH HHS P50-CA84724NCI NIH HHS R01 CA168676NCI NIH HHS R01-CA168676NCRR NIH HHS M01-RR03186NHLBI NIH HHS R01 HL109031NIDA NIH HHS P50 DA010075NIDA NIH HHS P50-DA010075-17NIDA NIH HHS P50-DA0197NIDA NIH HHS R21-DA024260NIDA NIH HHS T32-DA017629
6 · The paper itself

Abstract

introductionAdvancing the understanding of smoking cessation requires a complex and nuanced understanding of behavior change. To this end, ecological momentary assessments (EMA) are now being collected extensively. The time-varying effect model (TVEM) is a statistical technique ideally suited to model processes that unfold as behavior and nicotine dependence change. Coefficients are expressed dynamically over time and are represented as smooth functions of time.

methodsThe TVEM approach is demonstrated using data from a smoking-cessation trial. Time-varying effects of baseline nicotine dependence (a time-invariant covariate) and negative affect (a time-varying covariate) on urge to smoke during a quit attempt were estimated for monotherapy, combination therapy, and placebo groups. SAS syntax for conducting TVEM is provided so that readers can adapt it for their research.

resultsDuring the first 2 days after quitting, the association between negative affect and craving was significantly stronger among individuals in the placebo group, suggesting an early positive impact of treatment. For the monotherapy and combination therapy groups, during the second week of the quit attempt, baseline dependence was less strongly related to craving compared with the placebo group, indicating a different positive impact of treatments later in the quit attempt.

conclusionsThe results reveal information about the underlying dynamics that unfold during a quit attempt and how monotherapy and combination therapy impact those processes. This suggests possible mechanisms to target in an intervention and indicates timepoints that hold the greatest promise for effective treatment. TVEM is a straightforward approach to examining time-varying processes embedded in EMA.

Indexed as

CravingAffectCombined Modality TherapyFemaleHumansMaleModels, StatisticalPsychopharmacologySmokingSmoking CessationTime FactorsTobacco Use DisorderTreatment Outcome

Identifiers

PMID23975881
PMCPMC3977629
OpenAlexW2051276645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.